期刊文献+

强化降糖降压治疗2型糖尿病微血管病变的前瞻性研究 被引量:3

下载PDF
导出
摘要 目的为了解强化降糖、降压治疗对2型糖尿病微血管病变的影响。方法2001年7月~2005年2月对84例2型糖尿病患者进行随机、开放、对照、研究,共分成强化降糖、降压组(A组)、强化降糖组(B组)、强化降压组(C组)、一般降糖降压组(D组)。主要观察其尿微量白蛋白及视网膜病变情况。结果(1)强化降糖降压组,尿微量白蛋白/肌酐值明显降低(P<0.01),眼部病变发生亦明显减少(P<0.01)。(2)单纯强化降糖、强化降压组与一般降糖降压组比较,其微血管病变亦明显降低(P<0.05)。(3)单纯强化降糖与强化降压组间比较,其微血管病变降低(P<0.05)。结论强化降糖、降压治疗,对于预防2型糖尿病微血管病变有重要意义,但是在单纯降糖和降压方面,强化降糖治疗对于预防微血管病变优于单纯强化降压。
出处 《实用临床医学(江西)》 CAS 2005年第7期54-55,共2页 Practical Clinical Medicine
  • 相关文献

参考文献3

  • 1杨光燃,袁申元,潘素芳,朱良湘,郑全良,袁明霞.212例糖尿病患者慢性大血管与微血管并发症5年随访[J].微循环学杂志,2003,13(1):11-13. 被引量:3
  • 2United Kingdom Prospective Diabetes Study Group.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38[J].BMJ,1998,317:703~713.
  • 3Zhang L,Krzentowski G,Albert A,et al.Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control[J].Diabetes Care,2001,24:1 275~1 279.

二级参考文献8

  • 1潘孝仁,李光伟,刚勇,许开明,彭勇刚,陈川,征革凡,胡英华,刘平安,姜亚云,胡泽溪,胡秀英,席瑞敏,常青,孙心铨.糖耐量低减的特征及其与冠心病发生的关联[J].中华内分泌代谢杂志,1989,5(1):20-22. 被引量:46
  • 2全国眼底病协作组.糖尿病性视网膜病变分期标准[J].中华眼科杂志,1985,21:113-113.
  • 3[4]Bild D. The control of hypertension in persons with diabetes: A public health approach. Public Health Rep, 1987,102:522~529.
  • 4[5]Zanchetti A. Impact of hypertension and anti-hypertensive treatent on organ damage. Am J Cardiol, 1999,84:18~24.
  • 5[6]Michael Berger, Ingrid Muhlhauser. Diabetic care and patient oriented ooutcomes. JAMA, 1999,281:1676~1678.
  • 6[7]Hansson L, Zanchetti A. Carruthers SG, et al. Effect of intensive blood-pressure lowing and low-doseasprin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT)randomized trial. HOT Study Group. Lancent, 1998, 351: 1755~1762.
  • 7[8]UKPDS. 38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ, 1998, 7160:703.
  • 8袁申元.糖尿病微血管并发症防治的临床及实验研究[J].微循环学杂志,2000,10(4):11-12. 被引量:9

共引文献2

同被引文献17

  • 1章秋,潘天荣,何勇,陈明卫,胡红琳,王长江,杨明功.强化降糖治疗对2型糖尿病尿微量白蛋白的影响[J].安徽医科大学学报,2005,40(4):384-386. 被引量:3
  • 2杨文英,卜石.胰岛素使用方法的研究进展[J].中国实用内科杂志,2006,26(9):1301-1303. 被引量:14
  • 3王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
  • 4The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes [ J ]. N Engl J Med, 2008,358 (24) : 2560 - 2572.
  • 5Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complica- tions in insulin-dependent diabetes mellitus [ J ]. N Engl J Med, 1993,329 (14) :977 - 986.
  • 6The Diabetes Control and Complications Trial/Epidemi- ology of Diabetes Interventions and Complications Re- search Group. Retinopathy and nephropathy in patients with typeldiabetes four years after a trial of intensive therapy [ J J. N Engl J Med,2000,342 (6) :381 - 389.
  • 7UK Prospective Diabetes Study Group. Efficacy of ateno- lol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39[J]. BMJ, 1998, 317(7160) :713 -720.
  • 8Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascu- lar complications in Japanese patients with non-insulin- dependent diabetes mellitus:a randomized prospective 6- year study[ J]. Diabetes Res Clin Pract, 1995,28 (2) : 103 - 117.
  • 9Stanton RC, King GL. A complex interplay of factors causes diabetic nephropathy [ J ]. Metabolism, 2011,60 (5) :591 -593.
  • 10Nosadini R, Tonolo G. Relationship between blood glu- cose control, pathogenesis and progression of diabetic nephropathy[ J]. J Am Soc Nephrol, 2004 , 15 ( Suppl 1):1 -5.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部